CXCL9 and inflammatory bowel disease: Though the associations between IL-17 and MIG with IBD were not statistically significant, the directions of the effects were consistent (OR: 1.08, 95% CI: 0.78-1.49, P = 0.643 for IL-17 and OR: 1.13, 95% CI: 0.89-1.43, P = 0.316 for MIG) (Supplementary Table 6).